Zhi Su

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 27

Top Topics

Top Venues

Inorganic chemistry

ACS applied bio materials

Dalton transactions (Cambridge, England : 2003)

This page only lists publications with an associated author ORCID identifier.

Publications

Hao-Ming Li, Meng-Meng Wang, Yan Su, Hong-Bao Fang, Zhi Su
Mitochondria-Targeting Metallodrugs for Cancer Therapy: Perspectives from Cell Death Modes. ChemMedChem (2024)
Jin Yang, Meng-Meng Wang, Dong-Ping Deng, Hai Lin, Yan Su, Chen-Xu Shao, Si-Hui Li, Zheng-Hong Yu, Hong-Ke Liu, Zhi Su
Consolidating Organometallic Complex Ir-CA Empowers Mitochondria-Directed Chemotherapy against Resistant Cancer via Stemness and Metastasis Inhibition. Inorganic chemistry 63 (11) (2024)
Dongping Deng, Mengmeng Wang, Yan Su, Hongbao Fang, Yuncong Chen, Zhi Su
Iridium(III)-Based PD-L1 Agonist Regulates p62 and ATF3 for Enhanced Cancer Immunotherapy. Journal of medicinal chemistry (2024)
Meng-Meng Wang, Dong-Ping Deng, An-Min Zhou, Yan Su, Zheng-Hong Yu, Hong Ke Liu, Zhi Su
Functional Upgrading of an Organo-Ir(III) Complex to an Organo-Ir(III) Prodrug as a DNA Damage-Responsive Autophagic Inducer for Hypoxic Lung Cancer Therapy. Inorganic chemistry 63 (10) (2024)
Meng-Meng Wang, Dong-Ping Deng, An-Min Zhou, Yan Su, Zheng-Hong Yu, Hong Ke Liu, Zhi Su
Functional Upgrading of an Organo-Ir(III) Complex to an Organo-Ir(III) Prodrug as a DNA Damage-Responsive Autophagic Inducer for Hypoxic Lung Cancer Therapy. Inorganic chemistry (2024)
Meng-Meng Wang, Dong-Ping Deng, An-Min Zhou, Yan Su, Zheng-Hong Yu, Hong Ke Liu, Zhi Su
Functional Upgrading of an Organo-Ir(III) Complex to an Organo-Ir(III) Prodrug as a DNA Damage-Responsive Autophagic Inducer for Hypoxic Lung Cancer Therapy. Inorganic chemistry 63 (10) (2024)
Ziyou Zhang, Dongping Deng, Xiaoqian Xu, Jiang-Wei Zhang, Shuai Yan, Zhiying Guo, Hongliang Dong, Zhiqiang Chen, Zhi Su
Stretchable Tb-Tb Distance Regulates the Piezofluorochromic Behavior of Chiral Tb(III)-MOF upon Compression. JACS Au 4 (5) (2024)
Dongping Deng, Mengmeng Wang, Yan Su, Hongbao Fang, Yuncong Chen, Zhi Su
Iridium(III)-Based PD-L1 Agonist Regulates p62 and ATF3 for Enhanced Cancer Immunotherapy. Journal of medicinal chemistry 67 (8) (2024)
Jin Yang, Meng-Meng Wang, Dong-Ping Deng, Hai Lin, Yan Su, Chen-Xu Shao, Si-Hui Li, Zheng-Hong Yu, Hong-Ke Liu, Zhi Su
Consolidating Organometallic Complex Ir-CA Empowers Mitochondria-Directed Chemotherapy against Resistant Cancer via Stemness and Metastasis Inhibition. Inorganic chemistry 63 (11) (2024)
Ziyou Zhang, Dongping Deng, Xiaoqian Xu, Jiang-Wei Zhang, Shuai Yan, Zhiying Guo, Hongliang Dong, Zhiqiang Chen, Zhi Su
Stretchable Tb-Tb Distance Regulates the Piezofluorochromic Behavior of Chiral Tb(III)-MOF upon Compression. JACS Au 4 (5) (2024)
Hao-Ming Li, Meng-Meng Wang, Yan Su, Hong-Bao Fang, Zhi Su
Mitochondria-Targeting Metallodrugs for Cancer Therapy: Perspectives from Cell Death Modes. ChemMedChem 19 (15) (2024)
Jin Yang, Meng-Meng Wang, Dong-Ping Deng, Hai Lin, Yan Su, Chen-Xu Shao, Si-Hui Li, Zheng-Hong Yu, Hong-Ke Liu, Zhi Su
Consolidating Organometallic Complex Ir-CA Empowers Mitochondria-Directed Chemotherapy against Resistant Cancer via Stemness and Metastasis Inhibition. Inorganic chemistry (2024)
Wen-Juan Gao, Meng-Meng Wang, Yan Su, Zheng-Hong Yu, Hong-Ke Liu, Zhi Su
Self-Assembly Mitochondria-Targeting Donor-Acceptor Type Theranostic Nanosphere Activates ROS Storm for Multimodal Cancer Therapy. ACS applied bio materials 6 (2) (2023)
An-Min Zhou, Meng-Meng Wang, Yan Su, Zheng-Hong Yu, Hong-Ke Liu, Zhi Su
Switching the Mode of Cell Death between Apoptosis and Autophagy by Histone Deacetylase 6 Inhibition Levels. ChemMedChem 18 (5) (2023)
Wen-Juan Gao, Meng-Meng Wang, Yan Su, Zheng-Hong Yu, Hong-Ke Liu, Zhi Su
Self-Assembly Mitochondria-Targeting Donor-Acceptor Type Theranostic Nanosphere Activates ROS Storm for Multimodal Cancer Therapy. ACS applied bio materials 6 (2) (2023)
Yuanlei Huang, Mengdi Lv, Binglian Guo, Guojing Hu, Yong Qian, Zhi Su, Xuling Xue, Hong-Ke Liu
Selectively attacking tumor cells of Ru/Ir-arene complexes based on meclofenamic acid via cyclooxygenase-2 inhibition. Dalton transactions (Cambridge, England : 2003) 52 (20) (2023)
Wen-Juan Gao, Meng-Meng Wang, Yan Su, Zheng-Hong Yu, Hong-Ke Liu, Zhi Su
Self-Assembly Mitochondria-Targeting Donor-Acceptor Type Theranostic Nanosphere Activates ROS Storm for Multimodal Cancer Therapy. ACS applied bio materials 6 (2) (2023)
Yuanlei Huang, Mengdi Lv, Binglian Guo, Guojing Hu, Yong Qian, Zhi Su, Xuling Xue, Hong-Ke Liu
Selectively attacking tumor cells of Ru/Ir-arene complexes based on meclofenamic acid via cyclooxygenase-2 inhibition. Dalton transactions (Cambridge, England : 2003) 52 (20) (2023)
Wen-Juan Gao, Meng-Meng Wang, Yan Su, Zheng-Hong Yu, Hong-Ke Liu, Zhi Su
Self-Assembly Mitochondria-Targeting Donor-Acceptor Type Theranostic Nanosphere Activates ROS Storm for Multimodal Cancer Therapy. ACS applied bio materials 6 (2) (2023)
An-Min Zhou, Meng-Meng Wang, Yan Su, Zheng-Hong Yu, Hong-Ke Liu, Zhi Su
Switching the Mode of Cell Death between Apoptosis and Autophagy by Histone Deacetylase 6 Inhibition Levels. ChemMedChem 18 (5) (2023)
Wen-Juan Gao, Meng-Meng Wang, Yan Su, Zheng-Hong Yu, Hong-Ke Liu, Zhi Su
Self-Assembly Mitochondria-Targeting Donor-Acceptor Type Theranostic Nanosphere Activates ROS Storm for Multimodal Cancer Therapy. ACS applied bio materials (2023)
An-Min Zhou, Meng-Meng Wang, Yan Su, Zheng-Hong Yu, Hong-Ke Liu, Zhi Su
Switching the Mode of Cell Death between Apoptosis and Autophagy by Histone Deacetylase 6 Inhibition Levels. ChemMedChem 18 (5) (2023)
Yuanlei Huang, Mengdi Lv, Binglian Guo, Guojing Hu, Yong Qian, Zhi Su, Xuling Xue, Hong-Ke Liu
Selectively attacking tumor cells of Ru/Ir-arene complexes based on meclofenamic acid via cyclooxygenase-2 inhibition. Dalton transactions (Cambridge, England : 2003) (2023)
An-Min Zhou, Meng-Meng Wang, Yan Su, Zheng-Hong Yu, Hong-Ke Liu, Zhi Su
Switching the Mode of Cell Death between Apoptosis and Autophagy by Histone Deacetylase 6 Inhibition Levels. ChemMedChem (2022)
Zi-You Zhang, Guo-Xu Qin, Xiao-Min Li, Hong-Liang Dong, Shun Wan, Yong-Hong Ni, Jiang Liu, Zhi-Qiang Chen, Zhi Su
Enhanced Mechanical Stability and Proton Conductivity Performance from the Dense Mn(II)-Metal-Organic Framework to Porous Mn(II)-Fe(III)-Metal-Organic Framework. Inorganic chemistry 61 (38) (2022)
Meng-Meng Wang, Hao-Ming Li, Dong-Ping Deng, Yan Su, Zhi Su
Performance of Ir(III)-Based Anticancer Agents in the Treatment of Cisplatin-Resistant Cancer Cells. ChemMedChem 17 (16) (2022)
Meng-Meng Wang, Fu-Jie Xu, Yan Su, Yun Geng, Xiao-Ting Qian, Xu-Ling Xue, Ya-Qiong Kong, Zheng-Hong Yu, Hong-Ke Liu, Zhi Su
A New Strategy to Fight Metallodrug Resistance: Mitochondria-Relevant Treatment through Mitophagy to Inhibit Metabolic Adaptations of Cancer Cells. Angewandte Chemie (International ed. in English) 61 (27) (2022)